In this Newsletter:
- News: ESHI and ESMOFIR become ESHI-MT
- Storyboard: Garran Medical Imaging (Canberra/AUS)
- Webinar: Concepts for translational Research in Oncological Imaging
- Renew your mebership 2018!
- Case: xSPECT/CT of the lumbar spine and pelvis
- ESHI Course 2017: Video and Gallery
Representatives from ESHI and ESMOFIR are hereby announcing that these two societies will be merging, becoming the
European Society for Hybrid, Molecular and Translational Imaging (ESHIMT)
ESHI Story #3
Garran Medical Imaging
“We use xSPECT/CT and direct quantification often in combination with either MRI or ultrasound … and are currently developing the use of direct quantification in musculoskeletal and oncology diagnosis. In 2017 we have added Tc-PSMA imaging to our stable. Currently we are the only site in Australia offering this service and our experience to date is very positive.” – Dr Iain Duncan, founder of GMI
Concepts for translational Research in Oncological Imaging
Speaker: Prof. Dr. Konstantin Nikolaou
Date: January 31, 2018 – 17:00 (CET)
In the era of functional and molecular imaging, delivering information beyond morphology, size and simple metrics, multiparametric and multimodality imaging becomes ever more important….
ESHI Course 2017:
Hybrid Imaging in Oncology
December 14-15, 2017 | Vienna, Austria
Enjoy some impressions from our last educational course. More than 150 participants from 42 countries gathered in Vienna to learn more about the indications, limitations and comparative merits of each part in hybrid medical imaging in a wide range of oncologic conditions.